<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mukherjee</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Esper</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Buchheit</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Arters</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Adkins</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Ghannoum</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Salata</surname>
    <given-names>RA</given-names>
   </name>
  </person-group>
  <article-title>Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections</article-title>
  <source>BMC Infect Dis</source>
  <year>2017</year>
  <volume>17</volume>
  <issue>1</issue>
  <fpage>74</fpage>
  <pub-id pub-id-type="doi">10.1186/s12879-016-2177-8</pub-id>
  <pub-id pub-id-type="pmid">28088167</pub-id>
 </element-citation>
</ref>
